Minoxidil topique 2 % + spironolactone orale 100 mg face à Minoxidil topique 2 % + finastéride oral 5 mg

drugs used were ineffective in 2 (6.7%) cases in the minoxidil- spironolactone group and in 5 (16.7%) cases in the minoxidil- finasteride group. In addition, 13 (43.3%) and 16 (53%) cases in the minoxidil- spironolactone and minoxidil- finasteride groups, respec- tively, responded well to the treatment. The effect of treatment was excellent in 8 (56.7%) and 0 (0%) of the mentioned groups, respec- tively, and the mentioned difference was statistically significant (p: 0.01). The response to the treatment in the FPHL was not statisti-

Citation complémentaire (methode)

treatment was 4 months, and follow- up examinations were per- formed 2 and 4 months after the start of treatment. The efficacy of the treatment was evaluated by the following criteria: determina- tion of the degree of hair loss using the Ludwig grade for FPHL and the Norwood– Hamilton grade for MPHL, determination of physician satisfaction by clinical images using the physician global assessment score (no change, little, somewhat, good, and excellent), and deter- mination of patient satisfaction by clinical images according to the density and thickness of the hair shafts and the extent of hair loss (worsening, no change, and improvement).

Sadeghzadeh Bazargan A, Tavana Z, Dehghani A et al.. The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral finasteride in women with androgenic alopecia, female and male hair loss patterns: a blinded randomized clinical trial. Journal of Cosmetic Dermatology 2024, DOI 10.1111/jocd.15979. Citation sous licence CC-BY.

drugs used were ineffective in 2 (6.7%) cases in the minoxidil- spironolactone group and in 5 (16.7%) cases in the minoxidil- finasteride group. In addition, 13 (43.3%) and 16 (53%) cases in the minoxidil- spironolactone and minoxidil- finasteride groups, respec- tively, responded well to the treatment. The effect of treatment was excellent in 8 (56.7%) and 0 (0%) of the mentioned groups, respec- tively, and the mentioned difference was statistically significant (p: 0.01). The response to the treatment in the FPHL was not statisti-

Citation complémentaire (methode)

treatment was 4 months, and follow- up examinations were per- formed 2 and 4 months after the start of treatment. The efficacy of the treatment was evaluated by the following criteria: determina- tion of the degree of hair loss using the Ludwig grade for FPHL and the Norwood– Hamilton grade for MPHL, determination of physician satisfaction by clinical images using the physician global assessment score (no change, little, somewhat, good, and excellent), and deter- mination of patient satisfaction by clinical images according to the density and thickness of the hair shafts and the extent of hair loss (worsening, no change, and improvement).

Sadeghzadeh Bazargan A, Tavana Z, Dehghani A et al.. The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral finasteride in women with androgenic alopecia, female and male hair loss patterns: a blinded randomized clinical trial. Journal of Cosmetic Dermatology 2024, DOI 10.1111/jocd.15979. Citation sous licence CC-BY.

(70.0%) and 10 (33.3%) cases, respectively, p: 0.01), Figures 1,2.

Citation complémentaire (methode)

treatment was 4 months, and follow- up examinations were per- formed 2 and 4 months after the start of treatment. The efficacy of the treatment was evaluated by the following criteria: determina- tion of the degree of hair loss using the Ludwig grade for FPHL and the Norwood– Hamilton grade for MPHL, determination of physician satisfaction by clinical images using the physician global assessment score (no change, little, somewhat, good, and excellent), and deter- mination of patient satisfaction by clinical images according to the density and thickness of the hair shafts and the extent of hair loss (worsening, no change, and improvement).

Citation complémentaire (valeur)

spironolactone group than in the minoxidil- finasteride group (21

Sadeghzadeh Bazargan A, Tavana Z, Dehghani A et al.. The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral finasteride in women with androgenic alopecia, female and male hair loss patterns: a blinded randomized clinical trial. Journal of Cosmetic Dermatology 2024, DOI 10.1111/jocd.15979. Citation sous licence CC-BY.

(70.0%) and 10 (33.3%) cases, respectively, p: 0.01), Figures 1,2.

Citation complémentaire (methode)

treatment was 4 months, and follow- up examinations were per- formed 2 and 4 months after the start of treatment. The efficacy of the treatment was evaluated by the following criteria: determina- tion of the degree of hair loss using the Ludwig grade for FPHL and the Norwood– Hamilton grade for MPHL, determination of physician satisfaction by clinical images using the physician global assessment score (no change, little, somewhat, good, and excellent), and deter- mination of patient satisfaction by clinical images according to the density and thickness of the hair shafts and the extent of hair loss (worsening, no change, and improvement).

Citation complémentaire (valeur)

spironolactone group than in the minoxidil- finasteride group (21

Sadeghzadeh Bazargan A, Tavana Z, Dehghani A et al.. The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral finasteride in women with androgenic alopecia, female and male hair loss patterns: a blinded randomized clinical trial. Journal of Cosmetic Dermatology 2024, DOI 10.1111/jocd.15979. Citation sous licence CC-BY.

drugs used were ineffective in 2 (6.7%) cases in the minoxidil- spironolactone group and in 5 (16.7%) cases in the minoxidil- finasteride group. In addition, 13 (43.3%) and 16 (53%) cases in the minoxidil- spironolactone and minoxidil- finasteride groups, respec- tively, responded well to the treatment. The effect of treatment was excellent in 8 (56.7%) and 0 (0%) of the mentioned groups, respec- tively, and the mentioned difference was statistically significant (p: 0.01). The response to the treatment in the FPHL was not statisti-

Citation complémentaire (methode)

treatment was 4 months, and follow- up examinations were per- formed 2 and 4 months after the start of treatment. The efficacy of the treatment was evaluated by the following criteria: determina- tion of the degree of hair loss using the Ludwig grade for FPHL and the Norwood– Hamilton grade for MPHL, determination of physician satisfaction by clinical images using the physician global assessment score (no change, little, somewhat, good, and excellent), and deter- mination of patient satisfaction by clinical images according to the density and thickness of the hair shafts and the extent of hair loss (worsening, no change, and improvement).

Sadeghzadeh Bazargan A, Tavana Z, Dehghani A et al.. The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral finasteride in women with androgenic alopecia, female and male hair loss patterns: a blinded randomized clinical trial. Journal of Cosmetic Dermatology 2024, DOI 10.1111/jocd.15979. Citation sous licence CC-BY.

drugs used were ineffective in 2 (6.7%) cases in the minoxidil- spironolactone group and in 5 (16.7%) cases in the minoxidil- finasteride group. In addition, 13 (43.3%) and 16 (53%) cases in the minoxidil- spironolactone and minoxidil- finasteride groups, respec- tively, responded well to the treatment. The effect of treatment was excellent in 8 (56.7%) and 0 (0%) of the mentioned groups, respec- tively, and the mentioned difference was statistically significant (p: 0.01). The response to the treatment in the FPHL was not statisti-

Citation complémentaire (methode)

treatment was 4 months, and follow- up examinations were per- formed 2 and 4 months after the start of treatment. The efficacy of the treatment was evaluated by the following criteria: determina- tion of the degree of hair loss using the Ludwig grade for FPHL and the Norwood– Hamilton grade for MPHL, determination of physician satisfaction by clinical images using the physician global assessment score (no change, little, somewhat, good, and excellent), and deter- mination of patient satisfaction by clinical images according to the density and thickness of the hair shafts and the extent of hair loss (worsening, no change, and improvement).

Sadeghzadeh Bazargan A, Tavana Z, Dehghani A et al.. The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral finasteride in women with androgenic alopecia, female and male hair loss patterns: a blinded randomized clinical trial. Journal of Cosmetic Dermatology 2024, DOI 10.1111/jocd.15979. Citation sous licence CC-BY.